Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Angelin

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Communications Biology|October 4, 2022
Molecular programming modulates hepatic lipid metabolism and adult metabolic risk in the offspring of obese mothers in a sex-specific mannerChristina Savva, Luisa A Helguero, Marcela González-Granillo, et al.
Communications Biology|January 5, 2021
Obese mother offspring have hepatic lipidic modulation that contributes to sex-dependent metabolic adaptation later in lifeChristina Savva, Luisa A Helguero, Marcela González-Granillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansAnders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Atherosclerosis|August 24, 2005
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentrationAnna Abrahamsson, Sergey Krapivner, Ulf Gustafsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 15, 2008
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2Paolo Parini, Ulf Gustafsson, Matt A Davis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 2, 2010
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humansLena Persson, Guoqing Cao, Lars Ståhle, et al.
Circulation|September 29, 2004
ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liverPaolo Parini, Matthew Davis, Aaron T Lada, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretionMargaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.
Journal of Internal Medicine|July 10, 2023
Neurobiology of eating behavior, nutrition, and healthPatrick J Stover, Martha S Field, Mark L Andermann, et al.
Nature Communications|March 24, 2026
Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytesLin Chen, Zhanfang Kang, Jennifer Härdfeldt, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Communications Biology|October 4, 2022
Molecular programming modulates hepatic lipid metabolism and adult metabolic risk in the offspring of obese mothers in a sex-specific mannerChristina Savva, Luisa A Helguero, Marcela González-Granillo, et al.
Communications Biology|January 5, 2021
Obese mother offspring have hepatic lipidic modulation that contributes to sex-dependent metabolic adaptation later in lifeChristina Savva, Luisa A Helguero, Marcela González-Granillo, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 28, 2007
The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humansAnders Berkenstam, Jens Kristensen, Karin Mellström, et al.
Atherosclerosis|August 24, 2005
Common polymorphisms in the CYP7A1 gene do not contribute to variation in rates of bile acid synthesis and plasma LDL cholesterol concentrationAnna Abrahamsson, Sergey Krapivner, Ulf Gustafsson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 15, 2008
Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2Paolo Parini, Ulf Gustafsson, Matt A Davis, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 2, 2010
Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humansLena Persson, Guoqing Cao, Lars Ståhle, et al.
Circulation|September 29, 2004
ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liverPaolo Parini, Matthew Davis, Aaron T Lada, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 12, 2005
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretionMargaret E Brousseau, Margaret R Diffenderfer, John S Millar, et al.
Journal of Internal Medicine|July 10, 2023
Neurobiology of eating behavior, nutrition, and healthPatrick J Stover, Martha S Field, Mark L Andermann, et al.
Nature Communications|March 24, 2026
Sex-specific KDM6A-HNF4A-CREBH network controls lipoprotein cholesterol metabolism and atherosclerosis via epigenetic reprograming of hepatocytesLin Chen, Zhanfang Kang, Jennifer Härdfeldt, et al.
Pageof 7